3
Announcements
Trials
Browse
Landscape
Phase
Phase 1
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Sarcoma
1
Plasma cell
1
Lymphoid
1
Genitourinary
1
Dermatologic
1
Breast
1
Conditions
Melanoma
4
Sarcoma
2
Neoplasms
1
Multiple Myeloma
1
Lymphoma
1
Kidney Neoplasms
1
Breast Neoplasms
1
Interventions
aldesleukin
15
pembrolizumab
11
Cyclophosphamide
9
fludarabine phosphate
7
fludarabine
6
Nivolumab
6
Interleukin-2
6
atezolizumab
5
Radiotherapy
5
Ipilimumab
4
Interferon-alpha
4
Drug Therapy
4
Blood Specimen Collection
4
Radiosurgery
3
tremelimumab
2
temsirolimus
2
durvalumab
2
cemiplimab
2
Peripheral Blood Stem Cell Transplantation
2
Patient Reported Outcome Measures
2
Paclitaxel
2
Metformin
2
Interleukin-12 Subunit p35
2
Genistein
2
Gene Expression Profiling
2
Flow Cytometry
2
Filgrastim
2
Cetuximab
2
zanolimumab
1
vivitrol
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Kidney Neoplasms
×
Interferons
×
Dermatologic
×
Clear all
NCT00276536
2015-10-14
IFNa
The Cleveland Clinic
Phase 1
Completed
35 enrolled